Serum neurotensin, a new tumour marker for FHCC may discriminate it from HCC especially as a negative or normal value of alpha fetoprotein (AFP) tumour marker does not exclude an HCC [32]. The gene discussed is AFP; the disease is hepatocellular carcinoma.